WuXi Biologics (Cayman) Inc. (HKG:2269)
33.04
-0.06 (-0.18%)
Jun 26, 2026, 4:08 PM HKT
WuXi Biologics Employees
WuXi Biologics had 13,252 employees as of December 31, 2025. The number of employees increased by 677 or 5.38% compared to the previous year.
Employees
13,252
Change (1Y)
677
Growth (1Y)
5.38%
Revenue / Employee
1.83M HKD
Profits / Employee
412.17K HKD
Market Cap
135.85B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Innovent Biologics | 7,502 |
| Sichuan Kelun-Biotech Biopharmaceutical | 2,045 |
| Akeso | 3,761 |
| BeOne Medicines AG | 12,000 |
| Sino Biopharmaceutical | 21,435 |
| RemeGen | 3,048 |
| Biocytogen Pharmaceuticals (Beijing) | 1,443 |
| 3SBio | 6,109 |
WuXi Biologics News
- 4 days ago - WuXi Biologics' 25th Drug Substance Facility Completes First GMP Production, Manufacturing Process Execution with Zero Deviations - PRNewsWire
- 10 days ago - WuXi Biologics' Suzhou Biosafety Testing Center Received Fourth EMA GMP Certification, Enabling 19 Commercial Products for the European Market - PRNewsWire
- 20 days ago - WuXi Biologics Ireland Wins Top Honors at the 2026 Life Sciences Industry Awards - PRNewsWire
- 23 days ago - WuXi Biologics Singapore CRDMO Hub Completes Modular Topping-Out of Drug Product Facility - PRNewsWire
- 25 days ago - WuXi Biologics Named to CDP Supplier Engagement Assessment A List for the Second Consecutive Year - PRNewsWire
- 27 days ago - WuXi Biologics Transcript: Investor update - Transcripts
- 27 days ago - WuXi Biologics Slides: Investor update - Filings
- 4 weeks ago - WuXi Biologics Achieves GMP Release of 18th Drug Product Facility, Advancing Integrated Drug Substance to Drug Product Capabilities - PRNewsWire